Baker Hughes (BKR), a major player in the bio-tech industry, has been demonstrating strong performance over the past years.
Boston Trust Walden Corp sold 43,000 of its shares. Meanwhile, BKR investors received a decent 88% return in the last three years. Furthermore, BKR's CEO
Lorenzo Simonelli recently sold 114,286 shares. In remarkable news, Baker Hughes has secured a multi-year services agreement with
Woodside Energy to support Australian LNG Operations. Moreover, Baker Hughes' Q2 2024 earnings reports indicate strong financial health, with growth predicted for the long-term. A significant drop of 11.3% in short interest in BKR reflects positive investor sentiment. Meanwhile, BKR’s shares are going ex-dividend soon. Analysts are optimistic about Baker Hughes’ Q3 2024 earnings report. Despite reaching a 52-week high, investors are advised not to cash out just yet. Additional factors supporting Baker Hughes' solid growth are its enhanced Azerbaijan oilfields, reward of major contract for Hassi R'Mel Project and strong Q2 results.
Baker Hughes Company BKR News Analytics from Wed, 24 Jan 2024 08:00:00 GMT to Sun, 18 Aug 2024 17:34:56 GMT -
Rating 7
- Innovation 6
- Information 8
- Rumor -3
